Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DYNAGITO trial of tiotropium + olodaterol versus tiotropium in severe to very severe COPD
2014-002275-28Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Tiotropium + olodaterol fixed-dose combination with Tiotropium monotherapy (2 arms). Primary endpoint: Annualized rate of moderate to severe COPD exacerbation. Started Oct 2014; status: completed.
02
Drugs
tiotropiumolodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2014-002275-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002275-28.